Page 32 - Epidemiological studies on tuberculosis control and respiratory viruses

Chapter 6
102
Table 1 (continued). Characteristics of the study population by approximated illness severity
Comorbidities 7
Yes (CDC risk factor for resp. inf.)
169 (58%) 86 (30%) 36 (12%) 0 (0%)
120 (40%) 102 (34%) 56 (19%) 19 (6%)
PCR positive
For at least one virus Rhinovirus Human coronavirus Influenza A virus Respiratory syncytial virus Influenza B virus Enterovirus Adenovirus Human Metapneumovirus Parainfluenzavirus Human bocavirus Parechovirus
16 (6%) 6 (2%) 5 (2%) 0 (0%) 2 (1%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (0.3%) 1 (0.3%) 1 (0.3%)
54 (18%) 22 (7%) 15 (5%) 6 (2%) 4 (1%)
<0.001 0.002 0.026 0.031 0.686 1.000 1.000 1.000 1.000 0.624 0.373 1.000
41 (35%) 13 (11%) 8 (7%) 4 (3%) 8 (7%) 4 (3%) 1 (1%) 1 (1%) 6 (5%) 2 (2%) 0 (0%) 0 (0%)
80 (28%) 23 (8%) 12 (4%) 26 (9%) 11 (4%) 4 (1%)
66 (33%) 13 (7%) 12 (6%) 20 (10%) 6 (3%) 6 (3%) 0 (0%) 2 (1%)
0.294 0.338 0.490 0.100 0.234 0.346 0.193 0.535 0.246 0.081 1.000 NA
<0.001 0.004 0.082 <0.001 0.003 0.001 0.214 0.312 <0.001 0.181 0.578 1.000
Month of sampling
No Yes (other)
Unknown
October November December
54 (19%) 42 (14%) 33 (11%) 52 (18%) 56 (19%) 54 (19%)
50 (17%) 41 (14%) 37 (13%) 58 (20%) 58 (20%) 53 (18%)
0.983
10 (9%) 12 (10%) 11 (10%) 35 (30%) 25 (22%) 23 (20%)
28 (10%) 26 (9%) 20 (7%) 96 (34%) 58 (20%) 56 (20%)
18 (9%) 25 (13%) 43 (22%) 48 (24%) 37 (19%) 29 (15%)
0.002
<0.001
January February March
Asymptomatic Symptomatic
P-value1 0.001
Outpatients
Inpatients
ICU patients
P-value2
P-value3
HELIUS n (%)*
HELIUS n (%)*
n (%)*
n (%)*
n (%)*
1 (0.3%) 1 (0.3%) 1 (0.3%) 1 (0.3%) 3 (1%)
0 (0%) 1 (0.4%) 6 (2%) 0 (0%) 1 (0.4%) 0 (0%)
8 (4%) 1 (1%) 1 (1%) 0 (0%)
4 (1%) 1 (0.3%)